Talk:Rosuvastatin

From Wikipedia, the free encyclopedia

87.81.0.17 15:07, 26 November 2006 (UTC)I'm getting concerned that this article is becoming very reference-heavy. Much of the information now presented will be outdated at one point. Can we not rely on a few (4-5) references. For example, the link to Dr King's medical biochemistry page does not necessarily belong here - all statins act similarly, and a link to that page should be sufficient. JFW | T@lk 15:40, 22 Mar 2005 (UTC)

• the King reference has been moved to Talk:Cholesterol along with the intake-related sentence.
• MOA details deferred to Statin.
• Removal of dietary changes sentence => Statin
• Combined the Lancet oped items into a single numbered reference.

Do these changes in combination address part of your concerns? Courtland 14:34, 2005 Mar 26 (UTC)

Great, great. I did some further fiddling. I'm still not sure if that list of FDA documents needs to be there at all, and I removed the remark that it was the result of Googling.

Perhaps my quesiness is due to my worries about Wikipedia becoming a platform for trial lawyers. With the FDA under scrutiny, cerivastatin withdrawn and the tort system hungry any new & powerful drug runs the risk of getting this treatment. Wikipedia is for balance, and at the moment there seems to be no indication that rosuvastatin is worse than other synthetic statins re. risk of myopathy.

Good article, though. JFW | T@lk 11:33, 27 Mar 2005 (UTC)

The reason why I pulled together the FDA documents list was two fold. The first was in order to provide primary documents for people who are looking for some information to complement media coverage, which often embellishes on such documents. The second was that there is no such index elsewhere; the FDA does not provide (as far as I've found) a database organized such that a generic or trade name can be used as a query to retrieve an organized list of documents. I also didn't want to rely on AstraZeneca's own site as a source as I thought it would be better to consider the FDA as a (more) neutral party.

I can see your concern about legal resources. Do you know if Brittanica has run into this type of problem? I did think of the FDA document list as a seed for primary documents and it could be trimmed back to cut out some of the correspondence if the thought is that some of the back-and-forth is unencyclopedic (might be, yes). Other primary documents I was thinking about for inclusion here (not immediately) were things like peer reviewed publications related to study results; individual pubs could be replaced by meta-studies as (if) they emerge.

One thing that I'm concerned about, though, is the US-centricity of the article. Granted, drug companies do segregate the information that they provide on a market-by-market basis (due to legal reasons?) and I'm wondering if we should do the same or should try to provide a global view. I've not found a list of brand names used outside the US yet, but that would be useful to have. I know that some drugs have a dozen or more brand names for use in different countries (instances don't come to mind right now, unfortunately).

Thanks for the positive support. It's always appreciated :)

Courtland 14:37, 2005 Mar 27 (UTC)

[edit] Anti overload

This article is still >60% criticism/anti-drug company. We should be listing the trials of efficacy by name and academic reference. JFW | T@lk 07:29, 19 July 2006 (UTC)

[edit] Down with the bad, up with the good

Someone should add something about the very dorky commericals with the guy on the escalator in the endless hallways. I think its actual a pretty well known actor who does the commerical. I laugh every time I see it, especially when he gets the serious look and says to talk to YOUR doctor about Crestor! -Husnock 18:30, 15 August 2006 (UTC)

THIS ARTICAL HAS NOTHING TO DO WITH A TABLET P.C ALTHOUGH IT COMES UP WHEN YOU SEARCH FOR ONE!!!